Cost-utility of ferric carboxymaltose (Ferinject®) for iron-deficiency anemia patients with chronic heart failure in South Korea

Cost Effectiveness and Resource Allocation

Volumn 12, Issue 1, 2014, Pages

  Lim, Eun A ^a   Sohn, Hyun Soon ^b   Lee, Haeyoung ^a   Choi, Sang Eun ^a  

^a Korea University   (South Korea)

^b Ajou University   (South Korea)

Author keywords

Chronic heart failure; Cost utility; Cost effectiveness; Iron deficiency anemia; New York heart association (NYHA) functional class

Indexed keywords

FERRIC CARBOXYMALTOSE; PLACEBO;

ARTICLE; CLINICAL TRIAL (TOPIC); COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DRUG COST; HEALTH CARE SURVEY; HEART FAILURE; HOSPITAL CARE; HUMAN; IRON DEFICIENCY ANEMIA; NEW YORK HEART ASSOCIATION CLASS; OUTPATIENT CARE; QUALITY ADJUSTED LIFE YEAR; RESOURCE MANAGEMENT; SENSITIVITY ANALYSIS; SOUTH KOREA; TREATMENT OUTCOME;

EID: 84949115437     PISSN: None     EISSN: 14787547     Source Type: Journal    
DOI: 10.1186/1478-7547-12-19     Document Type: Article

References (28)

1. Ngo K, Kotecha D, Walters JA, Manzano L, Palazzuoli A, van Veldhuisen DJ, Flather M: Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients. Cochrane Database Syst Rev 2010.,20(1): CD007613
2. Heo JH, Kim HS, Jang BJ, Shin JG, Yang DH, Park HS, Jo YK, Chae SC, Jun JE, Park WH: Anemia is associated with higher mortality in severe heart failure. Korean Circ J 2005,35(10):773-778. Korean
3. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, Brosh D, Laniado S, Schwartz D, Yachnin T, Shapira I, Gavish D, Baruch R, Koifman B, Kaplan C, Steinbruch S, Iaina A: The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000,35(7):1737-1744.
4. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, Tsagalou EP, Maroulidis GD, Alexopoulos GP, Kanakakis JE, Anastasiou-Nana MI: Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 2006,48(12):2485-2489.
5. Kalra PR, Anagnostopoulos C, Bolger AP: The regulation and measurement of plasma volume in heart failure. J Am Coll Cardiol 2002, 39:1901-1908.
6. Anand IS, Chandrashekhar Y, Ferrari R: Pathogenesis of oedema in chronic anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J 1993, 70:357-362.
7. Mozaffarian D, Nye R, Levy WC: Anemia predicts mortality in severe heart failure. J Am Coll Cardiol 2003, 41:1933-1939.
8. Komajda M, Anker SD, Charlesworth A, Okonko D, Metra M, Di Lenarda A, Remme W, Moullet C, Swedberg K, Cleland JG, Poole-Wilson PA: The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J 2006,27(12):1440-1446.
9. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak W, Polonski L, Filippatos G, McMurray JJ, Anker SD, Ponikowski P: Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 2010,31(15):1872-1880.
10. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, ESC Committee for Practice Guidelines (CPG): ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European society of cardiology. Developed in collaboration with the heart failure association of the ESC (HFA) and endorsed by the European society of intensive care medicine (ESICM). Eur Heart J 2008, 29:2388-2442.
11. Haas JD, Brownlie T IV: Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr 2001, 131:676S-690S.
12. Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, Lok DJ, Rosentryt P, Torrens A, Polonski L, van Veldhuisen DJ, van der Meer P, Jankowska EA: Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J 2013,165(4):575-582.
13. Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagioia R, Febo O, Ferrari R, Fucili A, Moratti R, Tramarin R, Tavazzi L: Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J 2005, 26:2232-2237.
14. Ezekowitz JA, McAlister FA, Armstrong PW: Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 2003, 107:223-225.
15. Okonko DO, Grzeslo A, Witkowski T, Mandal AK, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P: Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemc patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 2008, 51:103-112.
16. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart RB, Pocock SJ, Poole-Wilson PA, Ponikowski P, FAIR-HF Trial Investigators: Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009,361(25):2436-2448.
17. Comin-Colet J, Lainscak M, Dickstein K, Filippatos GS, Johnson P, Lüscher TF, Mori C, Willenheimer R, Ponikowski P, Anker SD: The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study. Eur Heart J 2013,34(1):30-38.
18. Beck-da-Silva L, Piardi D, Soder S, Rohde LE, Pereira-Barretto AC, de Albuquerque D, Bocchi E, Vilas-Boas F, Moura LZ, Montera MW, Rassi S, Clausell N: IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. Int J Cardiol 2013,168(4):3439-3442.
19. Gutzwiller FS, Schwenkglenks M, Blank PR, Braunhofer PG, Mori C, Szucs TD, Ponikowski P, Anker SD: Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK. Eur J Heart Fail 2012,14(7):782-790.
20. Health Insurance Review and Assessment Service (HIRA), National Health Insurance Service (NHIS): 2011 national health insurance statistical yearbook. 2012. http://www.hira.or.kr/cms/open/04/02/03/01/__icsFiles/afieldfile/2012/12/10/2011.pdf
21. Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS: The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model. Health Technol Assess 2007,11(47):iii-iv. ix-248
22. Kirsch J, McGuire A: Establishing health state valuations for disease specific states: an example from heart disease. Health Econ 2000, 9:149-158.
23. Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW: Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant 2001, 20:1016-1024.
24. Calvert MJ, Freemantle N, Yao G, Cleland JG, Billingham L, Daubert JC, Bryan S, CARE-HF Investigators: Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. Eur Heart J 2005, 26:2681-2688.
25. Göhler A, Geisler BP, Manne JM, Kosiborod M, Zhang Z, Weintraub WS, Spertus JA, Gazelle GS, Siebert U, Cohen DJ: Utility estimates for decision-analytic modeling in chronic heart failure: health states based on New York heart association classes and number of rehospitalizations. Value Health 2009, 12:185-187.
26. Calvert MJ, Freemantle N, Cleland JG: The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study. Eur J Heart Fail 2005, 7:243-251.
27. Berry C, Murdoch DR, McMurray JJ: Economics of chronic heart failure. Eur J Heart Fail 2001,3(3):283-291.
28. Ahn J, Kim Y, Shin S, Park J: Asian Study on the Value for a QALY: Korean Results. Seoul: National Evidence-based Healthcare Collaborating Agency (NECA), NECA-C-12-001; 2013.